Brief: Uni-Bio Science Group Says Anabolic Agent For Osteoporosis & Ostealgia UNI-PTH Approved By NMPA For Clinical Trial
04/09/2020 11:52
Sept 4 (Reuters) - Uni-Bio Science Group Ltd 0690.HK :
* UNI-PTH APPROVED BY NMPA FOR CLINICAL TRIAL
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8PgMHR
Further company coverage: 0690.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsBrief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA
Brief: Uni-Bio Science Group Says Marketing Application Of Diquafosol Sodium Eye Drops Officially Approved By NMPA
Brief: Uni-Bio Science Declares Final Dividend Of Hk0.277 Cents Per Share